Big Shipment for Chinese Biotech Services: Strategic Partner Takes Stake in Key Subsidiary

Stock News

Aug 07

CH BIOTECH SER (08037) has announced that all conditions precedent under a supplementary agreement related to a strategic investment have been fulfilled, signaling the completion of an investment by BGI Songhe.

Following the transaction, BGI Songhe now holds a 6.25% stake in Pengbo (Hainan), which will continue to operate as a non-wholly owned subsidiary of the company. The financial statements of Pengbo (Hainan) will remain consolidated into the group's accounts.

The completion of this investment is expected to enhance Pengbo (Hainan)'s corporate profile and strengthen its capital base. It also underscores BGI Songhe's confidence in the future development of the Boron Neutron Capture Therapy (BNCT) center, as well as the company's commitment to providing BNCT services to cancer patients in need.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/news/1151358687"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1151358687\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1151358687?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-07 12:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1151358687","market":"sh","top_or_hot":-1,"title":"Big Shipment for Chinese Biotech Services: Strategic Partner Takes Stake in Key Subsidiary","media":"Stock News","content":"<p><b>CH BIOTECH SER</b> (08037) has announced that all conditions precedent under a supplementary agreement related to a strategic investment have been fulfilled, signaling the completion of an investment by BGI Songhe. <br><br>Following the transaction, BGI Songhe now holds a 6.25% stake in Pengbo (Hainan), which will continue to operate as a non-wholly owned subsidiary of the company. The financial statements of Pengbo (Hainan) will remain consolidated into the group's accounts. <br><br>The completion of this investment is expected to enhance Pengbo (Hainan)'s corporate profile and strengthen its capital base. It also underscores BGI Songhe's confidence in the future development of the Boron Neutron Capture Therapy (BNCT) center, as well as the company's commitment to providing BNCT services to cancer patients in need.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Big Shipment for Chinese Biotech Services: Strategic Partner Takes Stake in Key Subsidiary</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBig Shipment for Chinese Biotech Services: Strategic Partner Takes Stake in Key Subsidiary\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-08-07 12:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>CH BIOTECH SER</b> (08037) has announced that all conditions precedent under a supplementary agreement related to a strategic investment have been fulfilled, signaling the completion of an investment by BGI Songhe. <br><br>Following the transaction, BGI Songhe now holds a 6.25% stake in Pengbo (Hainan), which will continue to operate as a non-wholly owned subsidiary of the company. The financial statements of Pengbo (Hainan) will remain consolidated into the group's accounts. <br><br>The completion of this investment is expected to enhance Pengbo (Hainan)'s corporate profile and strengthen its capital base. It also underscores BGI Songhe's confidence in the future development of the Boron Neutron Capture Therapy (BNCT) center, as well as the company's commitment to providing BNCT services to cancer patients in need.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1219","symbol_name":"保健护理服务","start_time":0,"source_url":"","article_id":"1151358687","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1151358687","pubTimestamp":1786076532,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"CH BIOTECH SER (08037) has announced that all conditions precedent under a supplementary agreement related to a strategic investment have been fulfilled, signaling the completion of an investment by...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1219":"保健护理服务","BK1511":"疑似财技股","08037":"中国生物科技服务"},"translate_title":"中国生物技术服务大宗出货：战略合作伙伴入股关键子公司","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"08037":1},"content_text":"CH BIOTECH SER (08037) has announced that all conditions precedent under a supplementary agreement related to a strategic investment have been fulfilled, signaling the completion of an investment by BGI Songhe. Following the transaction, BGI Songhe now holds a 6.25% stake in Pengbo (Hainan), which will continue to operate as a non-wholly owned subsidiary of the company. The financial statements of Pengbo (Hainan) will remain consolidated into the group's accounts. The completion of this investment is expected to enhance Pengbo (Hainan)'s corporate profile and strengthen its capital base. It also underscores BGI Songhe's confidence in the future development of the Boron Neutron Capture Therapy (BNCT) center, as well as the company's commitment to providing BNCT services to cancer patients in need.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}